Blue Trust Inc’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-152
Closed -$32K 2816
2023
Q4
$32K Buy
152
+15
+11% +$3.23K ﹤0.01% 1119
2023
Q3
$26K Buy
137
+10
+8% +$2K ﹤0.01% 1092
2023
Q2
$25K Sell
127
-23
-15% -$4.57K ﹤0.01% 972
2023
Q1
$19K Buy
150
+5
+3% +$802 ﹤0.01% 1390
2022
Q4
$20K Buy
145
+31
+27% +$4K ﹤0.01% 1306
2022
Q3
$20K Buy
114
+3
+3% +$489 ﹤0.01% 1101
2022
Q2
$16K Buy
+111
New +$16K ﹤0.01% 1054

Blue Trust Inc's SGEN Position: Q1 2024 in Review

Blue Trust Inc sold out of Seagen Inc. Common Stock (SGEN) in Q1 2024, closing a stake of 152 shares — an estimated $32K sold.

Blue Trust Inc first reported a position in SGEN in Q2 2022 and held it in 7 quarters. The position peaked at $32K in Q4 2023. 0 funds tracked by Wall St. Rank hold SGEN as of Q1 2024.

  • Blue Trust Inc reported no remaining Seagen Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Blue Trust Inc sold 152 Seagen Inc. Common Stock shares in Q1 2024, an estimated $32K.
  • Blue Trust Inc first reported a position in Seagen Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Blue Trust Inc's Seagen Inc. Common Stock position peaked at $32K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.